SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce

7680691600029 CH-69160 A10BD07 07.06.2.

Reimbursement limitations:

JANUMET3

Pour le traitement des patients diabétiques de type 2 qui ne peuvent pas être suffisamment …

SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce
SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce
SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce
1 / 3
google

Details

Product number
6916001
CPT
-
Packaging group
160
Unit
Tablette(n)
Composition
metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), E 172 (rubrum), pro compresso, natrium 2.10 mg.

Articles (1)

Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Tabletten mit veränderter Wirkstofffreisetzung
160
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/05/2024
Patient information leaflet
Français
16/05/2024
Patient information leaflet
Italien
16/05/2024
Professional SmPC
Allemand
16/05/2024
Professional SmPC
Français
16/05/2024
Professional SmPC
Italien
16/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
2.1 MG Substance HBESI

Reimbursement information

Public price
CHF 60.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2023

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69160
Drug name
Sitagliptin Metformin XR Spirig HC, Tabletten mit veränderter Wirkstofffreisetzung
Galenic form
TABWF
ATC Code
A10BD07
Authorization status
Z
Dispensation category
B
First authorization
03/08/2023
Authorization expiration date
02/08/2028
IT number
07.06.2.
Domain
Human medicine
Field of application
Antidiabetikum

Packaging details

Description (FR)
SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce
Description (DE)
SITAGLIPTIN Metfor XR Spirig HC 50/500mg 160 Stk
Market launch
03/08/2023
Narcotic (BTM)
No

Original drug

Janumet, Filmtabletten
CHF 41.30
View original

Other packaging sizes

SITAGLIPTINE Metfor XR Spirig HC 50/500mg 60 pce
60 TABL
View
SITAGLIPTINE Metfor XR Spirig HC 50/1000mg 60 pce
60 TABL
View
SITAGLIPTINE Metfor XR Spirig HC 50/1000mg 160 pce
160 TABL
View
SITAGLIPTINE Metfor XR Spirig HC 100/1000mg 30 pce
30 TABL
View
SITAGLIPTINE Metfor XR Spirig HC 100/1000mg 90 pce
90 TABL
View